Get updates to this list
You’re signing up to all partnering opportunity alerts for:
Please check your inbox
Thank you for verifying your email. We have sent you a confirmation email containing a 6 digit verification code to complete your subscription
You've successfully created a subscription
The search results below each have a summary which you may find useful
in determining if the opportunity is what you’re looking for.
Certain diseases result in fibrosis of affected tissue. This 'scarring' causes reduced function compared to healthy tissue, which contributes to disease pathology. Wnt signalling is known to be important for tissue remodelling, such as that... more
A research institute from northern Germany, active in metrology, has developed a traceable, spatial calibration technology which helps to determine calibration of therapeutic ultrasound devices factors more easily.... more
This Irish SME has developed an animal warming and drying apparatus, optionally incorporating a radiant energy therapy means on upper & lower diffuser elements each deployable from a folded storage position. A combined air blower and heating... more
A French TTO acting on behalf major life science research labs in Paris Region, has designed and synthetized a new patented micro-particle which strongly improves the efficacy of a type of vaccines: ribonucleic acid (RNA) vaccines.
The proof... more
continuous release of the proteases encapsulated within at therapeutic doses during a sufficient period of time for the treatment of diseases which require a sustained protease administration during treatment... more
modulate the activation of the immune system have, therefore, a great potential in the identification of a therapeutic approach for a multiplicity of neurodegenerative and autoinflammatory pathologies. The inhibition... more
plan, they are looking for collaborative opportunities to exploit their nanoparticles for enhanced tumour targeting of new oligonucleotides with therapeutic potential.
Oligonucleotides, RNA (ribonucleic acid)... more
A French Technology Transfer Office (TTO) is acting on behalf several major engineering and medical schools in the Paris region. A research team operating in biochemical has designed a series of peptides acting as anti-inflammatories.
* Market... more
A French Technology Transfer Office (TTO) is acting on behalf of major life science research labs in Paris region, has designed and patented pseudo-viral like particles (VLPs) to prevent and cure allergy or auto-immune diseases like multiple... more
Cervical cancer is the third most common cancer in women world-wide, with approx. 530,000 new cases and 275,000 deaths per year. In contrast to other cancers it mainly affects young women with a maximum of incidence below 30 years of age.
An Andalusian University in the south of Spain has developed a combination kit of GAL (1-15) or a pharmaceutically acceptable salt therof useful for augmenting and/or providing faster onset of the therapeutic effect... more
The Japanese company has developed two platform technologies: an in silico drug screening technology for small molecules (#1) and a new modality for therapeutic peptide (#2).
Technology #1 is being powered up... more
treatment in most of them leads to the continuous search for new therapeutic targets.
LRRK2 is a protein that has been classified as a member of the ROCO superfamily (Ras-like GTPase). Its physiological role is... more
and it has received very positive feedback from the patients, support groups and medical organizations. It makes a patient's life easier, improves a patient's motivation for treatment and intensifies the therapeutic... more
therapeutic interventions with the latest digital solutions in a secure, user friendly web-based environment. It uses a blended approach where therapeutic interventions are supported... more
therapeutic effect, especially in the treatment of tumors resistant to officinal cytostatic.
The dosage of the half maximal inhibitory concentration (IC50, i.e. dose required for the death of 50% of tumor cells)... more
compounds), to be used for therapeutic and non-therapeutic purposes.
The center is looking to establish license, research cooperation or technical cooperation agreements with industrial... more
with cytotoxic compounds linked to anti-THSD7A antibodies to optimize site directed drug application and minimize therapeutic side effects.
Due to the strong relation to several tumor entities, THSD7A can be... more
The biomedical use of proteins (i.e., enzymes, growth factors, hormones) has been widely explored by the biotechnological industry including enzyme replacement therapy (ERT).
One of the major bottlenecks regarding therapeutic... more
Prostate cancer is the second most common cancer in males. An estimated 1.1 million men worldwide were diagnosed with prostate cancer in 2012, accounting for 15% of the cancers diagnosed in males. The selection of the therapeutic... more